Princeton, New Jersey, June 19, 2006 - Covance (NYSE: CVD) today announced the appointment of Jeffrey J. Stoddard, M.D. as Covance's Vice President, Medical and Scientific Affairs, Risk Management and Postmarketing Programs. In this capacity, Dr. Stoddard will lead Covance's risk management and postmarketing business and have responsibility for providing scientific and technical leadership in these important areas.
